TNDM:NASDAQ
Tandem Diabetes Care Inc
15,84 USD
arrow_downward
-1,98%(-0,32) 1D
15,80 USD
arrow_downward
-0,25% (-0,040)bedtimeAfter hours
Closed: 7-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
15,80 USD
High
16,64 USD
Low
15,73 USD
Mkt. cap
1,10 млд
Avg. vol.
1,95 млн
Volume
2,11 млн
52-wk high
29,65 USD
52-wk low
12,26 USD
EPS
-0,93 USD
Beta
1,66
Shares outstanding
69,58 млн
No. of employees
2 миң
Open
15,80 USD
High
16,64 USD
Low
15,73 USD
Mkt. cap
1,10 млд
Avg. vol.
1,95 млн
Volume
2,11 млн
52-wk high
29,65 USD
52-wk low
12,26 USD
EPS
-0,93 USD
Beta
1,66
Shares outstanding
69,58 млн
No. of employees
2 миң
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 апта мурун
Tandem Diabetes Care (TNDM) Slips 0.84% to $16.43 as Traders Watch Support at $15.61 - High Beta Stocks
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2,5 миң
Foundedянв. 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com